Related Experiment Video
Updated: Apr 28, 2026

23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
17.7K
AIDS and psychiatry, revisited
1Royal Cornhill Hospital, Aberdeen.
International Journal of Psychiatry in Clinical Practice
|June 19, 2014
Summary
Human Immunodeficiency Virus (HIV) psychiatry remains relevant, though its brain assault mechanisms are unclear. Early detection of central nervous system (CNS) involvement in HIV/AIDS is improving with neuropsychological assessments.
Area of Science:
- Neurology
- Psychiatry
- Infectious Diseases
Background:
- The psychiatric aspects of Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) are under-recognized but clinically significant.
- Understanding the neurological impact of HIV on the brain is crucial for patient care.
- Central nervous system (CNS) involvement can be an early manifestation of HIV infection.
Purpose of the Study:
- To review the current understanding of HIV-associated psychiatric disorders.
- To highlight the importance of early detection of CNS involvement in HIV/AIDS.
- To discuss the potential for psychiatric symptoms as an initial presentation of AIDS.
Main Methods:
- Literature review on HIV neurology and psychiatry.
- Analysis of case studies presenting with neurological and psychiatric symptoms.
- Discussion of advancements in neuropsychological assessment for CNS involvement.
Main Results:
- Neuropsychological assessments are improving early detection of CNS involvement in HIV.
- HIV may exhibit brain specificity, with cerebral issues preceding other physical signs.
- Psychiatric symptoms can be a presenting feature of AIDS.
Conclusions:
- The precise mechanisms of HIV's neurological assault require further investigation.
- Continued attention to the psychiatric and neurological manifestations of HIV/AIDS is warranted.
- Integrated care approaches are essential for managing patients with HIV and CNS complications.
Related Concept Videos
Drug Therapy
445
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
445
Psychosis and Antipsychotic Drugs: Overview
1.2K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.2K
Psychosis: Goals of Pharmacotherapy
699
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
699
Diagnostic and Statistical Manual of Mental Disorders (DSM)
2.0K
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
2.0K
Pulmonary Tuberculosis I
1.7K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Retrovirus Life Cycles
42.9K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
42.9K

